Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep473 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Refeeding syndrome – an unexpected clinical case

Puga Francisca , Baptista Patrícia , França Margarida , Araújo Correia João

Refeeding syndrome can be defined as the potentially fatal shift in fluids and electrolytes that may occur after the reintroduction of feeding after a period of starvation or fasting in malnourished patients. The hallmark characteristic of refeeding syndrome is hypophosphatemia. However, the syndrome is complex and may also feature abnormal sodium and fluid balance, changes in glucose, protein and fat metabolism, hypokalemia, hypomagnesemia and thiamine deficiency. The underly...

ea0073aep254 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Characterization of glycemic profile and glucose-lowering treatment in hospitalized patients of a central hospital by main diagnosis and length of stay

Patrícia Rosinha , Teixeira Sofia , Cláudia Amaral , Cardoso Helena

IntroductionGlycemic control during hospitalization has an impact on the length of hospital stay (LOS) and infection rates. This knowledge has led to a growing concern with hyperglycemia and its repercussions.ObjectivesThis study aims to evaluate the glycemic profile and diabetes mellitus (DM) treatment paradigm of hospitalized patients in a central hospital by main diagnosis and LOS.Me...

ea0070aep652 | Pituitary and Neuroendocrinology | ECE2020

Acrodat – a useful tool to manage acromegaly patients

Alves Helena , Almeida Ferreira Marta , Tavares Patrícia , Ramalho Diogo , Machado Catarina , Almeida Lucia , Correia Sara , João Oliveira Maria

Introduction: Acromegaly is a rare condition associated with metabolic abnormalities, risk of cardiovascular complications and increased mortality. Even when biochemical control is achieved, following surgery or medical treatment, patients still complain about disease-related symptoms.Material and Methods: Retrospective study of acromegaly patients, followed in an Endocrine outpatient clinic. Clinical and biochemical data was recorded. ACRODAT was used t...

ea0070aep1034 | Hot topics (including COVID-19) | ECE2020

Characterization of dyslipidaemia and association of lipoprotein(A) plasma levels with metabolic control in young adults with type 1 diabetes

Inácio Isabel , Ferrreira Sara , Rosinha Patrícia , Azevedo Teresa , Alves Márcia , Dantas Rosa , Balsa Ana Margarida , Guimarães Joana

Introduction: The 2019 European Society of Cardiology/European Atherosclerosis Society lipid guidelines changed the cardiovascular risk categories and LDL-C goals, and suggests that lipoprotein(a) [Lp(a)] measurement should be considered at least once in adult person’s lifetime. Although young people with type 1 diabetes (T1DM) without major cardiovascular risk factors (CVRF) were previously considered to be at low or moderate risk, they are at least at moderate risk bas...